Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

The diaTribe Foundation’s sixth annual “Solvable Problems in Diabetes” in Barcelona brought together more than 140 leaders to discuss challenges and opportunities in...
Xofluza was recently approved to treat the flu in higher-risk populations – people with diabetes or other chronic conditions, and people over age 65 – and to prevent...
Regular eye screenings are important for people with diabetes. Learn more about diabetes-related retinopathy screenings from diabetes advocates Renza and Grumpy
As we demand more nutritious and sustainable food, big food companies must make adjustments to their products, practices, and marketing
Maria shares her experiences and strategies for managing blood sugar levels while studying abroad
Low-cost monthly subscription services from mySugr, One Drop, DarioHealth, and Livongo
A trial is enrolling over 3,000 individuals living with type 2 diabetes and chronic kidney disease
Control-IQ the first AID system with automatic correction boluses and no fingersticks CGM (Dexcom G6); cleared for those ages 14 and older; launch in January 2020
The new BioSense ketone breath meter offers unlimited, effortless ketone measurements – just blow into the device
Adam’s presentation at Friends for Life 2019
A new paper suggests that as people with diabetes increase their time in range, healthcare costs decrease
A new pill combines Jardiance, Tradjenta, and metformin to help people with type 2 diabetes manage blood glucose levels more easily, and in many different ways
SGLT-2 inhibitors and GLP-1 agonists recommended as first-line therapies; Farxiga offers heart health benefits in people with and without diabetes
The SGLT-2 inhibitor becomes the first diabetes medicine approved to treat kidney disease and reduce the risk of hospitalization for heart failure in people with type 2...
The FDA finds that some versions of extended-release metformin contain excessive amounts of a cancer-causing chemical called NDMA
Nine industry leaders share insights on better diabetes outcomes at lower costs – The diaTribe Foundation’s 4 th annual Musings Under the Moon
Omada Health and Abbott partner to bring FreeStyle Libre to Omada Health’s digital coaching program for people with type 2 diabetes
Every February the Spare a Rose, Save a Child campaign raises funds to provide insulin and other diabetes supplies to children with type 1 in under-resourced countries...
$99 Cash Card Program provides 3000-3800 units of any combination of Novo Nordisk analog insulins in vials or pens. NovoLog authorized generics are available at half...
The tool for people with diabetes to use with their healthcare professionals will launch in early 2020, extending CGM further! Features include fully disposable...

Pages